U.S. Oil and Gas Stock News

NasdaqCM:CMPX
NasdaqCM:CMPXBiotechs

A Look At Compass Therapeutics (CMPX) Valuation After Recent Trial Milestones And FDA Clearance

Clinical milestones and earnings set the context for Compass Therapeutics stock Compass Therapeutics (CMPX) has been in focus after reaching the planned survival event threshold in its Phase 2/3 COMPANION-002 trial for biliary tract cancer, along with FDA clearance for its CTX-10726 investigational program. These developments come as the company reported a full year 2025 net loss of US$66.49 million and a fourth quarter net loss of US$15.72 million, figures that help frame current...
NasdaqCM:INDI
NasdaqCM:INDISemiconductor

A Look At Indie Semiconductor (INDI) Valuation After $150 Million Convertible Note Selloff

indie Semiconductor (INDI) is back in focus after announcing and completing a US$150 million convertible note offering. The share price then fell sharply as investors reacted to potential dilution and higher debt. See our latest analysis for indie Semiconductor. The financing news landed on a stock that was already under pressure, with a 7 day share price return of 29.23% and a 90 day share price return of 43.94%. The 1 year total shareholder return of 11.60% and 5 year total shareholder...
NasdaqGS:VSNT
NasdaqGS:VSNTMedia

Versant Media Group (VSNT) Balances Buybacks, Dividend and Digital Pivot Is Capital Allocation Truly Aligned?

Versant Media Group, Inc. recently reported full-year 2025 results showing lower sales of about US$6.69 billion and net income of US$930 million, while its board approved a US$0.375 quarterly dividend and authorized up to US$1 billion in share repurchases. Alongside these capital return moves, management is emphasizing disciplined bolt-on acquisitions, a shift toward digital and ad-supported platforms, and maintaining a strong balance sheet as a newly independent media company. Next, we’ll...
NYSE:GENI
NYSE:GENIHospitality

Genius Sports Legend Deal Recasts Data Monetization And Advertising Outlook

Genius Sports (NYSE:GENI) announced a definitive agreement to acquire Legend, expanding its live sports data and ad tech capabilities. The company reported revenue and EBITDA figures for 2025 alongside the Legend deal, highlighting a shift in its data monetization strategy. Genius Sports also unveiled new partnerships, including a direct integration with Magnite for real time ad activation. An expanded collaboration with NBC Sports Regional Networks will use AI driven tools for augmented...
NYSE:FVRR
NYSE:FVRRProfessional Services

Fiverr Downgrades And Investor Exit Test Confidence In Turnaround Story

Multiple analysts have downgraded Fiverr International (NYSE:FVRR), signaling a reset in sentiment around the platform's business outlook. The Optimist Fund, a major institutional investor and former top holder of FVRR, has fully exited its position. These moves come as the market focuses on Fiverr's customer acquisition challenges and pressure on active buyer trends and revenue expectations. For you as an investor, the reaction in NYSE:FVRR has been sharp. The stock closed at $11.33, with...
NasdaqGS:TUSK
NasdaqGS:TUSKEnergy Services

Mammoth Energy Services (TUSK) TTM Loss Of US$85.1 Million Reinforces Bearish Narratives

Mammoth Energy Services FY 2025 results: revenue steady, losses persist Mammoth Energy Services (TUSK) has posted another loss making quarter, with Q3 FY 2025 revenue of US$14.8 million and basic EPS of a US$0.25 loss, while trailing twelve month figures show EPS of a US$1.76 loss on revenue of US$186.3 million. Over recent periods the company has seen quarterly revenue move between US$16.4 million and US$14.8 million in FY 2025, compared with US$53.2 million in Q4 FY 2024, as EPS ranged from...
NasdaqCM:RGC
NasdaqCM:RGCPharmaceuticals

DOJ Probe Puts Regencell Bioscience Finances And Investor Outlook Under Strain

The U.S. Department of Justice has opened an investigation into Regencell Bioscience Holdings for potential violations of federal securities laws. Authorities have requested extensive documentation related to the company’s operations, finances, and accounting. Regencell expects substantial legal expenses and acknowledges the possibility of fines or settlements that may not be fully covered by insurance. For shareholders of Regencell Bioscience Holdings, ticker NasdaqCM:RGC, this...
NasdaqGS:JOYY
NasdaqGS:JOYYInteractive Media and Services

Is JOYY (JOYY) Pricing Reflect Its Strong DCF And P/E Signals?

If you are wondering whether JOYY's share price really reflects what the business is worth, you are not alone. This article is going to focus squarely on that question. JOYY recently closed at US$60.80, with returns of 1.9% over 7 days, a 1.8% decline over 30 days, a 6.1% decline year to date, a 33.8% gain over 1 year and a 139.0% gain over 3 years, while the 5 year return stands at a 36.6% decline. These mixed returns have kept investors focused on how sentiment around JOYY is shifting, and...
NYSE:UAA
NYSE:UAALuxury

Under Armour Taps SXSW Jacket To Highlight Sustainability And Valuation Story

UNLESS COLLECTIVE, a subsidiary of Under Armour (NYSE:UAA), has been selected as the partner for SXSW's first official Filmmakers Jacket. The collaboration centers on a plant-based, regenerative festival jacket created for SXSW's 2026 event. This represents a move for Under Armour into higher profile sustainable festival merchandise tied to a major cultural gathering. Under Armour, best known for performance athletic wear, is using UNLESS COLLECTIVE to expand into eco-focused apparel tied...
NasdaqGS:HSIC
NasdaqGS:HSICHealthcare

Henry Schein Sales Surge And CEO Stock Sale Refocus Investor Attention

Henry Schein (NasdaqGS:HSIC) reported its strongest sales growth in 15 quarters, highlighting a shift in recent operating momentum. The company introduced a new multi year value creation plan that outlines its priorities for the coming years. A large stock sale by the CEO followed these announcements, drawing attention to insider activity at the company. Henry Schein enters this news cycle with its shares at $80.17 and a value score of 5, reflecting how the market has been pricing the...
NYSE:SCCO
NYSE:SCCOMetals and Mining

Strait Of Hormuz Closure Puts Southern Copper Costs And Valuation In Focus

Military conflict in the Middle East has led to the closure of the Strait of Hormuz, disrupting a key global energy and shipping route. This chokepoint closure is creating volatility across mining and metals companies, including Southern Copper (NYSE:SCCO), as fuel supply and transport risks rise. Investors are watching how higher energy costs and logistical challenges could affect operating expenses and margins for producers such as Southern Copper. Southern Copper, listed as NYSE:SCCO, is...
NYSE:APG
NYSE:APGConstruction

APi Group Leans On Inspection First Model To Build Cash And Scale

APi Group (NYSE:APG) reports record revenue levels alongside higher profitability. The company highlights 21 consecutive quarters of double digit inspection growth in North America. Management continues to pursue bolt on acquisitions while expanding free cash flow margins. APi Group, listed on the NYSE under the ticker APG, focuses on safety and specialty services with an inspection first model that aims to drive recurring revenue. Recent updates around record revenue, stronger...
NYSE:NOMD
NYSE:NOMDFood

Is Nomad Foods (NOMD) Starting To Look Interesting After A 47% One Year Share Price Slide

If you are wondering whether Nomad Foods at US$10.33 is starting to look like value or a value trap, you are not alone. That is exactly what this article will unpack. The stock has seen an 8.3% decline over the last week, an 18.0% drop over the past month, and is down 47.0% over the past year, putting long term holders under pressure and raising fresh questions about risk and return. Recent coverage has focused on how prolonged share price weakness and earlier acquisition activity have...
NasdaqCM:SPT
NasdaqCM:SPTSoftware

Sprout Social (SPT) Is Up 9.1% After Mixed Q4 Results and New 2026 Outlook – What’s Changed

Sprout Social recently reported fourth-quarter 2025 revenue of US$120.89 million and a net loss of US$10.74 million, alongside filing a US$23.19 million shelf registration for 3,573,414 Class A shares tied to its employee stock ownership plans. The combination of improving loss per share, new 2026 revenue guidance, and potential employee share issuance offers fresh insight into how Sprout Social is funding growth and rewarding staff while remaining unprofitable. Against this backdrop of...
NYSE:ETSY
NYSE:ETSYMultiline Retail

Etsy PrintKK Partnership Puts AI And Automation At Center Stage

PrintKK has launched a global, integrated print on demand solution for Etsy sellers, adding automation and AI powered design tools. The integration gives sellers access to a wide range of customizable products and automated fulfillment aimed at international buyers. This development introduces new ways for Etsy merchants to test products without holding inventory and could influence the variety of items available on the marketplace. Etsy, listed on the NYSE under ticker NYSE:ETSY, is...
NasdaqGS:TBLA
NasdaqGS:TBLAInteractive Media and Services

Taboola.com (TBLA) Valuation Check After Swing To Profit And New Revenue Guidance

Why Taboola.com (TBLA) is back on investor radar Taboola.com (NasdaqGS:TBLA) is in focus after reporting fourth quarter and full year 2025 results that shifted from a prior year net loss to net income, along with new 2026 revenue guidance. See our latest analysis for Taboola.com. The earnings release and fresh 2026 guidance have put Taboola.com back in focus, with a 1 day share price return of 6.92% and 7 day share price return of 11.11% contrasting with a weaker year to date share price...
NYSE:ACA
NYSE:ACAConstruction

Arcosa Refocuses On Infrastructure As Barge Sale Reshapes Earnings Story

Arcosa (NYSE:ACA) announced the sale of its barge business and is shifting its focus toward construction materials and engineered structures. The move is aimed at concentrating resources on U.S. infrastructure and power related businesses that management views as core to the company. Arcosa, trading at $111.28 at the last close, is coming off a strong longer term stretch, with the stock up 37.0% over the past year and 87.8% over three years. The company is also ahead 76.5% over five years,...
NYSE:LTH
NYSE:LTHHospitality

Life Time Group Launches US$500m Buyback As Valuation Signals Diverge

Life Time Group Holdings (NYSE:LTH) has approved a new $500 million share repurchase program. The buyback plan targets the company's common stock and is intended to support long term shareholder value. This authorization adds a fresh capital allocation lever for the fitness and lifestyle operator. Life Time Group Holdings, trading at $26.12 per share, is coming off a mixed share price run, with a 51.2% gain over three years but a 13.3% decline over the past year. In the shorter term, the...
NasdaqGS:PGNY
NasdaqGS:PGNYHealthcare

Progyny Adds INVO Fertility Clinic As Network Grows And Shares Lag

INVO Fertility has joined the Progyny (NasdaqGS:PGNY) provider network, adding its clinic to Progyny's fertility benefits platform. The partnership expands access to employer sponsored fertility care for patients in Wisconsin and nearby regions. This development broadens Progyny's provider footprint and increases potential touchpoints with covered employees seeking fertility treatment. Progyny runs a fertility benefits platform that connects employer sponsored health plans with a network of...
NYSE:MPT
NYSE:MPTHealth Care REITs

Medical Properties Trust Faces Prospect Bankruptcy Test For Rent Resilience

Medical Properties Trust (NYSE:MPT) has issued a response to Prospect Medical Group's bankruptcy filing. The company is outlining potential operational impacts related to Prospect's tenant status and leased hospital assets. Investors are watching for updates on rental income exposure, asset utilization, and any changes to existing lease arrangements. Medical Properties Trust focuses on owning and leasing hospital and healthcare facilities, so any disruption involving a key tenant like...
NasdaqGS:AARD
NasdaqGS:AARDPharmaceuticals

A Look At Aardvark Therapeutics (AARD) Valuation After HERO Trial Pause And Volatile Share Price Moves

Aardvark Therapeutics (AARD) has put its Phase 3 HERO trial for ARD-101 in Prader-Willi Syndrome on hold after reversible cardiac issues at higher doses, triggering delays, legal scrutiny, and sharp share price swings. See our latest analysis for Aardvark Therapeutics. The HERO trial pause has been the clear driver of volatility, with Aardvark Therapeutics’ 1-day share price return of 15.1% coming after sharp declines, including a 57.6% 30-day share price loss and a 50.4% 1-year total...
NYSE:KVUE
NYSE:KVUEPersonal Products

Institutional Exit Tests Kenvue’s Valuation, Dividend Strength And Momentum

SCCM Enhanced Equity Income Fund has fully exited its position in Kenvue (NYSE:KVUE). The decision highlights ongoing business challenges, including US consumer spending pressures and delayed seasonality in key product lines. Operational headwinds in China, rising competition, and market share erosion are central to current investor concerns. Kenvue, trading at $18.19, is drawing fresh attention after the SCCM Enhanced Equity Income Fund chose to exit its position entirely. The stock is up...
NYSE:SEMR
NYSE:SEMRSoftware

Semrush AI Push With Spotlight 2026 And ChatGPT Integration Under Adobe Deal

Semrush Holdings (NYSE:SEMR) has launched Spotlight 2026, an AI focused marketing conference centered on brand visibility in the AI search era. The company has introduced an official Semrush app within ChatGPT to bring its marketing toolkit into the conversational AI environment. These moves come as Semrush continues through its planned acquisition process with Adobe. Semrush operates as a digital marketing platform, with tools that help businesses manage search visibility, content, and...
NasdaqGS:ROOT
NasdaqGS:ROOTInsurance

Does Root’s (ROOT) Strong 2025 Results but Softer Q4 Profit Reframe Its Profitability Story?

Root, Inc. previously reported fourth-quarter 2025 revenue of US$397 million, up from US$326.7 million a year earlier, with net income of US$5.1 million compared with US$20.9 million. For 2025 overall, Root lifted revenue to US$1.52 billion and increased net income to US$38.3 million, but its fourth-quarter profit was lower than the prior year despite higher sales. Next, we’ll examine how Root’s higher full-year revenue and earnings, alongside weaker quarterly profit, may influence its...